A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...
SUNNYVALE, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that ...
Adding the drug enzalutamide to standard hormone therapy reduced the risk of premature death by more than 40% in patients ...
SUNNYVALE, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and pioneer of robotic-assisted surgery, announced that the Food ...
SAN FRANCISCO--(BUSINESS WIRE)--ArteraAI, the developer of multimodal artificial intelligence-based prognostic and predictive cancer tests, announced the validation of its first multimodal artificial ...
News-Medical.Net on MSN
Breakthrough combo therapy lowers death risk in recurrent prostate cancer
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...
A new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback